Publications by authors named "Greeshma S S Nayudu"
Article Synopsis
- The effectiveness of sotagliflozin, a medication for type 2 diabetes, in reducing cardiovascular and renal events remains unclear, prompting a meta-analysis to further investigate its benefits.
- The study involved analyzing data from various medical databases for research published between January 2018 and January 2022, focusing on the quality and outcomes of included studies.
- Results showed a significant reduction in hospitalizations and cardiovascular-related deaths among patients taking sotagliflozin, particularly at higher doses, although evidence for protecting renal function is still inconclusive.
The COVID-19 pandemic has caused havoc in the health sector. Inflammatory cytokines play an important role in the disease condition. Existing evidence has provided certain insights into the repurposing of the drugs.
View Article and Find Full Text PDF